Qiagen NV

NYSE:QGEN   3:29:47 PM EDT
+0.07 (+0.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)11.23B
Current PE24.23
Forward PE 21.41
2yr Forward PE 23.67
See more stats
Estimates Current Quarter
Revenue$489.13 Million
Adjusted EPS$0.47
See more estimates
10-Day MA$49.56
50-Day MA$49.66
200-Day MA$46.67
See more pivots

Qiagen NV Stock, NYSE:QGEN

Hulsterweg 82, Venlo, Limburg 5912 PL
Phone: +31.77.355.66.00
Number of Employees: 6028


QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.